| Quarter | Score |
|---|---|
| 2022-Q1 | 47.7 |
| 2022-Q2 | 43.0 |
| 2022-Q3 | 43.1 |
| 2022-Q4 | 43.3 |
| 2023-Q1 | 44.5 |
| 2023-Q2 | 46.3 |
| 2023-Q3 | 47.1 |
| 2023-Q4 | 50.9 |
| 2024-Q1 | 62.4 |
| 2024-Q2 | 58.8 |
| 2024-Q3 | 72.9 |
| 2024-Q4 | 72.9 |
| 2025-Q1 | 73.0 |
| 2025-Q2 | 72.8 |
| 2025-Q3 | 72.9 |
| 2025-Q4 | 73.0 |
| 2026-Q1 | 73.0 |
| 2026-Q2 | 73.2 |
Funds reducing exposure or consensus momentum fading
Trading +202.6% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold NUVB. Avg conviction: 0.0%. Net trimming. First tracked at $2.29 (current +202.6% vs tracked).
Greenlight Capital has 0.0% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Greenlight Capital | 0.0% | Hold |
| Citadel Advisors | 0.0% | Reduce |